Events

Accelerating Innovation at the Intersection of Medtech and Health Care

January 24th
12:00 PM- 1:00 PM

Register now

group of business people reviewing documents

In this webinar, we will discuss the industry trends and dynamics around digital health & technologies (Connected devices, SaMD, AI, RWE) in the medtech industry, discuss market influences and imperative to change and the nuances of the challenges in integrating device insights with health information systems.

Accelerating Innovation at the Intersection of Medtech and Health Care

January 24th
12:00 PM- 1:00 PM

Register now

  1. Agenda
  2. Speakers

Accelerating Innovation at the Intersection of Medtech and Health Care

January 24th
12:00 PM- 1:00 PM

Register now

Agenda

Accelerating Innovation at the Intersection of Medtech and Health Care

Medtech is at the tipping point of digital innovation. 90% of medtech executives are prioritizing digital adoption. Many devices and medtech products are accompanied by companion apps but app abandonment is a real problem for the industry. On the whole there are over 350,000 digital health apps today, of which 83% were installed fewer than 5,000 times. Companion apps are often not compelling to patients because they work in isolation from the patient’s EHR, care team.

Yet, the promise of digital health, RWE generation, connected devices, and SaMD’s, presents a new frontier that can fundamentally change the way medtech companies interact with their health care customers, patients and consumers to improve care outcomes and experiences for each user in the value chain. Efforts to connect devices to care workflows, surface insights at the point of care and integrate them into the patient’s clinical record are being made in order to deliver on these promises.

However, the challenges of ingesting the correct clinical data, difficulties in integrating device insights into the clinical workflow, and scaling these integrations despite the lack of interoperability of health information systems creates an extremely expensive and high barrier to leveraging the full potential of digital innovation in the health care context.

In this webinar, we will discuss the industry trends and dynamics around digital technologies, discuss market influences and imperative to change and the nuances of these challenges in integrating device insights with health information systems. Specifically, we will cover:

  • What are the trends in the industry around digital technologies, the driving forces and imperatives that necessitate these? What have been some examples of success and some of the biggest challenges faced by the industry so far?
  • Why does integrating insights from digital devices into care work streams matter and what is the value lost by not doing it?
  • What are the challenges faced when attempting to integrate insights from digital devices into care work streams?
  • Challenges of equity, what are the impacts as you try to cross the digital divide, will this exacerbate differences for disadvantaged people. Technology is often seen as actually bridging the gap between populations, how does this play out in medtech?
  • How to begin this journey and overcome the challenges of implementing connected digital health solutions.
  • What are the challenges providers face when implementing such solutions and what’re the best ways to approach these conversations with your customers?

Our live webinar will be recorded. If you are unable to attend, please register and we will follow-up with a recording of the program.

Speakers

Kyle Fennelly- Innovaccer – Area Vice President Digital Health Solutions

Current Responsibilities

Kyle leads Innovaccers strategy in Digital Health Solutions for the Medical Device Industry. He has +10 years of experience in the Medical Device Industry specializing in healthcare system acquisitions and partnership strategies. His current role has him consulting with Medical Device Organizations on how to transform patient care and outcomes by leveraging healthcare data. He is currently an MBA Candidate at LSU and holds a Bachelors in Biomedical Engineering.


Christian Howell , Aetion, Senior Vice President & General Manager, Medical Device and Diagnostic Group at Aetion

Christian is responsible for a cross-functional team focused on the development of innovative new business models and the execution of Aetion’s Medical Device and Diagnostic strategy. Recognized as a forward-thinking industry leader in real world evidence and value-based healthcare, Christian has presented on payment system transformation and partnership strategies with healthcare professionals around the world. He has presented on strategic partnership development and value-based healthcare at the G20 in Riyadh, Saudi Arabia, The Harvard Business Review Forum on Value-based Healthcare, and numerous other events globally.

Christian brings 20 years of medical device leadership experience to Aetion. He was previously the Vice President of Value Based Healthcare at Medtronic. Christian has held positions of increasing responsibility in Sales, Product Marketing, Strategic Marketing, Sales Leadership, and Business Development during his career.

Ken Stein, Boston Scientific – Senior Vice President, Chief Medical Officer for Rhythm Management and Global Health Policy at Boston Scientific

Dr. Ken Stein is currently Senior Vice President and Chief Medical Officer for Rhythm Management and Global Health Policy at Boston Scientific.

Ken is a Phi Beta Kappa graduate of Harvard College, and earned his MD from New York University School of Medicine. He completed his medical internship, residency, cardiology and cardiac electrophysiology training at The New York-Presbyterian Hospital/Weill Cornell Medical Center. Prior to joining Boston Scientific in 2009, Dr. Stein held the position of Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University where he was widely published, authoring over 125 peer-reviewed scientific publications.

Dr. Stein currently oversees the clinical trials, medical safety and medical education and clinical communications for Boston Scientific’s Rhythm Management business as well as leading the corporate Global Health Policy team tasked with shaping the company’s policies with respect to global health care delivery and reimbursement.

Dr. Stein serves on the board of the Boston Scientific Political Action Committee and on Advisory Boards of Optum Labs and IBM Watson Health – Life Sciences. Since 2013, he has also served on the board of Children’s HeartLink, a registered nonprofit organization that trains and mentors medical teams in underserved parts of the world to diagnose and treat children with heart disease. Founded in 1969, Children’s HeartLink currently supports partner hospitals in Brazil, China, India, Malaysia, Ukraine and Vietnam.

Hear From Us

Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.